SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13E3/A - Going private transaction by certain issuers: [Amend]
SEC Accession No. 0001193125-20-257121
Filing Date
2020-09-29
Accepted
2020-09-29 06:18:06
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13E3/A d81869dsc13e3a.htm SC 13E3/A 27272
  Complete submission text file 0001193125-20-257121.txt   29103
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filed by) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Subject) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13E3/A | Act: 34 | File No.: 005-88972 | Film No.: 201205970
SIC: 2834 Pharmaceutical Preparations